HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leonardina Ciccarelli Selected Research

glimepiride (Amarel)

5/2006Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
11/2005Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.
9/2005Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
7/2005A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
5/2005Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
5/2004Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
2/2003Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leonardina Ciccarelli Research Topics

Disease

16Type 2 Diabetes Mellitus (MODY)
08/2013 - 02/2003
14Insulin Resistance
09/2013 - 08/2004
8Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2007 - 05/2004
7Hypertension (High Blood Pressure)
05/2006 - 02/2003
5Body Weight (Weight, Body)
06/2010 - 04/2003
2Inflammation (Inflammations)
10/2006 - 04/2006
2Diabetes Mellitus
09/2005 - 07/2003
2Coronary Disease (Coronary Heart Disease)
10/2004 - 02/2003
2Hypercholesterolemia
05/2003 - 04/2003
1Overweight
05/2008
1Homocysteinemia
05/2006
1Glucose Intolerance
01/2006
1Hyperlipoproteinemias
10/2004
1Hyperlipidemias (Hyperlipidemia)
10/2004
1Cardiovascular Diseases (Cardiovascular Disease)
10/2004
1Obesity
08/2004
1Essential Hypertension
07/2004
1Metabolic Diseases (Metabolic Disease)
05/2003
1Metrorrhagia (Spotting)
04/2003

Drug/Important Bio-Agent (IBA)

10LipidsIBA
11/2006 - 04/2003
9Metformin (Glucophage)FDA LinkGeneric
08/2013 - 06/2003
9Glucose (Dextrose)FDA LinkGeneric
08/2013 - 07/2003
9Rosiglitazone (Avandia)FDA Link
05/2008 - 05/2004
7glimepiride (Amarel)FDA LinkGeneric
05/2006 - 02/2003
6Pioglitazone (Actos)FDA Link
06/2010 - 05/2004
4Insulin (Novolin)FDA Link
08/2013 - 08/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010 - 10/2006
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
08/2013 - 08/2004
3ResistinIBA
08/2013 - 05/2008
3Pharmaceutical PreparationsIBA
01/2009 - 10/2004
3Telmisartan (Micardis)FDA Link
11/2006 - 07/2004
3Lipoprotein(a)IBA
05/2006 - 02/2003
3Doxazosin (Cardura)FDA LinkGeneric
04/2006 - 06/2005
2ProinsulinIBA
08/2013 - 06/2010
2AdiponectinIBA
06/2010 - 05/2008
2C-Reactive ProteinIBA
06/2010 - 04/2006
2LeptinIBA
05/2008 - 11/2006
2IrbesartanFDA LinkGeneric
11/2006 - 06/2005
2HomocysteineIBA
05/2006 - 02/2003
2oxidized low density lipoproteinIBA
01/2006 - 04/2003
2LDL CholesterolIBA
01/2006 - 04/2003
2HDL CholesterolIBA
01/2006 - 04/2003
2CholesterolIBA
01/2006 - 04/2003
2Triglycerides (Triacylglycerol)IBA
01/2006 - 04/2003
2Hypoglycemic Agents (Hypoglycemics)IBA
09/2005 - 05/2005
2Plasminogen Activator Inhibitor 1IBA
07/2005 - 05/2005
2Hypolipidemic Agents (Antihyperlipidemics)IBA
10/2004 - 02/2003
2FluvastatinFDA Link
10/2004 - 04/2003
2Antihypertensive Agents (Antihypertensives)IBA
07/2004 - 07/2003
2repaglinide (Prandin)FDA Link
06/2003 - 02/2003
1AdipokinesIBA
09/2013
1Arginine (L-Arginine)FDA Link
08/2013
1Glucagon (Glukagon)FDA Link
08/2013
1Exenatide (Byetta)FDA Link
08/2013
1C-PeptideIBA
08/2013
1Angiotensin Receptor AntagonistsIBA
08/2010
1Sitagliptin Phosphate (Januvia)FDA Link
06/2010
1Type 1 Angiotensin ReceptorIBA
11/2006
1atorvastatin drug combination amlodipineFDA Link
10/2006
1Interleukin-6 (Interleukin 6)IBA
10/2006
1Matrix Metalloproteinases (MMPs)IBA
05/2006
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
05/2006
1Tissue Inhibitor of Metalloproteinase-1IBA
05/2006
1NitritesIBA
04/2006
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2006
1NitratesIBA
04/2006
1AcarboseFDA LinkGeneric
01/2006
12,4-thiazolidinedione (thiazolidinedione)IBA
11/2005
1rosiglitazone-metformin combinationFDA Link
05/2005
1Fenofibrate (CiL)FDA LinkGeneric
10/2004
1Fibric Acids (Fibrates)IBA
10/2004
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2004
1TabletsIBA
10/2004
1Apoprotein(a) (Apolipoprotein (a))IBA
08/2004
1Protein Isoforms (Isoforms)IBA
08/2004
1Nifedipine (Adalat)FDA LinkGeneric
08/2004
1eprosartan (Teveten)FDA Link
07/2004
1Lipoproteins (Lipoprotein)IBA
05/2004
1PerindoprilFDA LinkGeneric
07/2003
1candesartanIBA
07/2003
1Reducing AgentsIBA
05/2003
1Carnitine (L-Carnitine)FDA LinkGeneric
05/2003
1Orlistat (Xenical)FDA Link
04/2003
1DiureticsIBA
02/2003
1Plasminogen Activators (Plasminogen Activator)IBA
02/2003
1Thyroxine (Levothyroxine)FDA LinkGeneric
02/2003

Therapy/Procedure

8Therapeutics
06/2010 - 05/2003
6Glycemic Control
06/2010 - 02/2003
1Drug Therapy (Chemotherapy)
06/2003
1Diet Therapy (Therapy, Diet)
05/2003